Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fang, Jie
NCT06109818: Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis	Recruiting	2	129	RoW	ICP-488 Tablets, ICP-488 Placebo	Beijing InnoCare Pharma Tech Co., Ltd.	Moderate to Severe Plaque Psoriasis	10/24	11/24
TQH3906-II-01, NCT06542614: Treatment of Moderate to Severe Plaque Psoriasis	Recruiting	2	120	RoW	TQH3906 capsules, Placebo of TQH3906 capsules	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	Plaque Psoriasis	01/25	09/25
Yuan, Bo
TQC3721-II-03, NCT06527144: A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease	Recruiting	2	240	RoW	3mg TQC3721 Suspension for Inhalation, 6mg TQC3721 Suspension for Inhalation, Placebo TQC3721 suspension for inhalation	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Pulmonary Disease, Chronic Obstructive	02/25	12/25
Yin, Zhaoping
TQC3721-II-03, NCT06527144: A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease	Recruiting	2	240	RoW	3mg TQC3721 Suspension for Inhalation, 6mg TQC3721 Suspension for Inhalation, Placebo TQC3721 suspension for inhalation	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Pulmonary Disease, Chronic Obstructive	02/25	12/25